Meloset
Indicated to address sleep disruptions to manage circadian cycle timing and support rest stabilisation.
- Category
- Sleep Management
- Active ingredient
- Melatonin
- Route
- Oral use
- Form
- Tablet
- Strengths
- 3mg
Prescription and consultation requirements for Meloset vary by destination and are determined by the fulfilment partner.
Meloset details
- Condition
- Circadian Rhythm Sleep Disorders
- Alternative names
- melatonin
- Therapeutic class
- Melatonin Receptor Agonist
- Pharmacological class
- Nutraceutical
- Known off-label uses
- insomnia
- Contraindications
- hypersensitivity to melatonin
- Minor side effects
- headache; drowsiness
- Moderate side effects
- vivid dreams; mild dizziness; nausea
- Serious side effects
- severe anaphylaxis, requires immediate medical attention
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Aristo Pharmaceuticals
- Onset Time
- 30–60 minutes
- Duration
- 4–6 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Fluvoxamine; Zolpidem
- Age restrictions
- Approved for adults over eighteen years.
Patient summary
indicated to address sleep disruptions to manage circadian cycle timing and support rest stabilisation.
Mechanism of action
Stimulates central MT1 and MT2 receptors, replicating endogenous hormone secretion to coordinate the biological sleep clock.
Pregnancy and breastfeeding
TGA Category C: Safety not fully established. Breastfeeding: Consult a clinician.